AAAAAA

   
Results: 1-10 |
Results: 10
Postmenopausal hormone use following a 3-year randomized clinical trial
Authors: Barrett-Connor, E Espeland, MA Greendale, GA Trabal, J Johnson, S Legault, C Kritz-Silverstein, D Einhorn, P
Citation: E. Barrett-connor et al., Postmenopausal hormone use following a 3-year randomized clinical trial, J WOMEN H G, 9(6), 2000, pp. 633-643
Age and other risk factors for neuropsychologic decline in patients undergoing coronary artery bypass graft surgery
Authors: Smith, MH Wagenknecht, LE Legault, C Goff, DC Stump, DA Troost, BT Rogers, AT
Citation: Mh. Smith et al., Age and other risk factors for neuropsychologic decline in patients undergoing coronary artery bypass graft surgery, J CARDIOTHO, 14(4), 2000, pp. 428-432
Genetic diversity of eleven European pig breeds
Authors: Laval, G Iannuccelli, N Legault, C Milan, D Groenen, MAM Giuffra, E Andersson, L Nissen, PH Jorgensen, CB Beeckmann, P Geldermann, H Foulley, JL Chevalet, C Ollivier, L
Citation: G. Laval et al., Genetic diversity of eleven European pig breeds, GEN SEL EVO, 32(2), 2000, pp. 187-203
Genetic parameters and genetic trends in the Chinese x European Tiameslan composite pig line. I. Genetic parameters
Authors: Zhang, SQ Bidanel, JP Burlot, T Legault, C Naveau, J
Citation: Sq. Zhang et al., Genetic parameters and genetic trends in the Chinese x European Tiameslan composite pig line. I. Genetic parameters, GEN SEL EVO, 32(1), 2000, pp. 41-56
Genetic parameters and genetic trends in the Chinese x European Tiameslan composite pig line. II. Genetic trends
Authors: Zhang, SQ Bidanel, JP Burlot, T Legault, C Naveau, J
Citation: Sq. Zhang et al., Genetic parameters and genetic trends in the Chinese x European Tiameslan composite pig line. II. Genetic trends, GEN SEL EVO, 32(1), 2000, pp. 57-71
C-reactive protein and hormone replacement therapy - Response
Authors: Cushman, M Sakkinen, PA Tracy, RP Legault, C Barrett-Connor, E Stefanick, ML Kessler, CM Judd, HL
Citation: M. Cushman et al., C-reactive protein and hormone replacement therapy - Response, CIRCULATION, 102(13), 2000, pp. E96-E97
A randomized, blinded trial of the antioxidant pegorgotein: No reduction in neuropsychological deficits, inotropic drug support, or myocardial ischemia after coronary artery bypass surgery
Authors: Butterworth, J Legault, C Stump, DA Coker, L Hammon, JW Troost, BT Royster, RL Prough, DS
Citation: J. Butterworth et al., A randomized, blinded trial of the antioxidant pegorgotein: No reduction in neuropsychological deficits, inotropic drug support, or myocardial ischemia after coronary artery bypass surgery, J CARDIOTHO, 13(6), 1999, pp. 690-694
Effect of hormone replacement therapy on the validity of the Friedewald equation in postmenopausal women: The Postmenopausal Estrogen/Progestins Interventions (PEPI) trial
Authors: Legault, C Stefanick, ML Miller, VT Marcovina, SM Schrott, HG
Citation: C. Legault et al., Effect of hormone replacement therapy on the validity of the Friedewald equation in postmenopausal women: The Postmenopausal Estrogen/Progestins Interventions (PEPI) trial, J CLIN EPID, 52(12), 1999, pp. 1187-1195
Effect of postmenopausal hormones on inflammation-sensitive proteins - ThePostmenopausal Estrogen/Progestin Interventions (PEPI) Study
Authors: Cushman, M Legault, C Barrett-Connor, E Stefanick, ML Kessler, C Judd, HL Sakkinen, PA Tracy, RP
Citation: M. Cushman et al., Effect of postmenopausal hormones on inflammation-sensitive proteins - ThePostmenopausal Estrogen/Progestin Interventions (PEPI) Study, CIRCULATION, 100(7), 1999, pp. 717-722
Genetics of colour variation
Authors: Legault, C
Citation: C. Legault, Genetics of colour variation, GENETICS OF THE PIG, 1998, pp. 51-69
Risultati: 1-10 |